April 3rd closing price for innovative drugs mainline continues to guide sentiment for three consecutive days

robot
Abstract generation in progress

Bid at 9:25, in a one-price limit board for all-in orders: Zhongyou Capital (cross-border settlement), Cuiwei Shares (digital yuan/cryptocurrency), Beiken Energy (oil and gas), Huaiyuan Communications (optical communications) in four directions—do not focus; the guidance is invalid.
According to the bidding strategy: bidding on a one-price limit board can focus; guidance directed toward a target has a purpose; bidding on a one-price limit board in different directions—funds return to look for the top marquee.
Today’s focus is Tianyao: it opened high by 9.78% versus yesterday, which is weaker, but its uniqueness is still there; however, the whole sector has no positive follow-through—even Meinuo opened below water. Yesterday, the tool play Yao-controlled Zhongyao Pharmaceutical Holdings also turned weaker and opened slightly green of 0.92%. At this time, the test has come. We have to ask a soul-searching question: where exactly is the uniqueness?
The answer is actually clear—Tianyao.
After the close, it looks like Tianyao led the innovative drug theme and held up despite the sector’s major internal divergence. After the holiday, making new highs again should be no problem. The other optical-fiber names do not yet have uniqueness; even when the main theme is weakening, you still can’t provide a uniquely effective target. So after the holiday, you still need to watch Tianyao.

[Taojuba]

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin